AngioDynamics, Inc. (ANGO) financial statements and ratios from SEC XBRL: revenue $320.17M (TTM), net margin -11.5%, revenue growth 9.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $320.17M |
| Net Margin | -11.5% |
| Revenue Growth (YoY) | 9.5% |
| EPS Growth (YoY) | 6.0% |
| FCF Growth (YoY) | -103.5% |
| EV / EBITDA | 39.0 |
| Price / Book | 3.83 |
| Price / Sales | 2.14 |
| FCF Yield | -12.0% |
| Altman Z-Score | 2.74 (grey) |
| Sector P/E (Healthcare) | 21.6 |
ANGO overview · ANGO earnings · ANGO KPIs · ANGO investor relations · ANGO ownership · ANGO peers · ANGO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.